XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.3
SHARE CAPITAL (Tables)
 6 Months Ended
Jun. 30, 2023
Share Capital  
SCHEDULE OF INFORMATION ABOUT CLASSES OF SHARE CAPITAL

   As of 
   June 30, 2023   December 31, 2022 
   Number   US$   Number   US$ 
   of shares   ‘000   of shares   ‘000 
Authorized:                    
Ordinary shares of US$ 0.024 each   200,000,000    4,800    200,000,000    4,800 

 

   June 30, 2023 
   Number   RMB 
   of shares   ‘000 
Outstanding and fully paid:          
Ordinary shares of US$ 0.024 each          
At January 1, 2023   805,785    1,288 
Issuance of new shares for equity financing   854,139    1,486 
Conversion of Long-term notes into common shares   2,275    4 
Issuance of new shares – share-based compensation to CEO and CFO   53,262    93 
Issuance of new shares – share-based compensation to Directors   168,000    292 
Issuance of new shares – share-based compensation to Employee   211,721    369 
At June 30, 2023 *   2,095,182    3,532 

 

*The number of shares reflected the one-for-ten reverse split effective on September 18, 2023.
SCHEDULE OF PRINCIPAL ASSUMPTIONS USED IN VALUATION

 

 

Grant date (investors and placement agent, respectively)   February 17, 2021 
Share price at date of grant (investors and placement agent, respectively)   US$4.45 
Exercise price at date of grant (investors and placement agent, respectively)   US$3.57 & 4.46 
Volatility    107%
Warrant life    5 years 
Dividend yield    0%
Risk-free interest rate    0.57%
Average fair value at grant date   US$3.54 
 
Grant date (investors and placement agent, respectively)   June 14, 2021 
Share price at date of grant (investors and placement agent, respectively)   US$3.15 
Exercise price at date of grant (investors and placement agent, respectively)   US$3.42 & 4.35 
Volatility    115%
Warrant life    5 years 
Dividend yield    0%
Risk-free interest rate    0.80%
Average fair value at grant date   US$2.50 
  
Grant date (investors and placement agent, respectively)  October 4, 2022 
Share price at date of grant (investors and placement agent, respectively)  US$0.58 
Exercise price at date of grant (investors and placement agent, respectively)  US$0.82 & 0.75 
Volatility   104%
Warrant life   5 years 
Dividend yield   0%
Risk-free interest rate   3.96%
Average fair value at grant date  US$0.43 
 
SCHEDULE OF SUMMARY OF THE WARRANT ACTIVITY

           Weighted 
           Average 
           Remaining 
       Average   Contractual 
   Number of   Exercise   Term in 
   Warrants   Price   Years 
Outstanding at December 31, 2022   370,175   $21.7    4.02 
Exercisable at December 31, 2022   370,175    21.7    4.02 
Issued   —    —    — 
Exercised   —    —    — 
Expired   —    —    — 
Outstanding at June 30, 2023 *   370,175    21.7    3.52 
Exercisable at June 30, 2023 *   370,175   $21.7    3.52 

 

*The number of shares reflected the one-for-ten reverse split effective on September 18, 2023